SCHEMBL17359127

SCHEMBL17359127

CN(CCCO)C(=O)c1ccc(Cl)c(S(=O)(=O)NO)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 3/20 0.52
▸ PDK1 Q15118 1/20 0.52
▸ PDK3 Q15120 1/20 0.52
▸ PDK4 Q16654 1/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ GSTO1 P78417 1/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8051170 0.93 GSTO1 (0.46) PDK2PDK1PDK3PDK4SMN1; SMN2
SCHEMBL11886812 0.88 GAA (0.45) PDK2PDK1PDK3PDK4SMN1; SMN2
SCHEMBL8061101 0.86 SMN1; SMN2 (0.44) PDK2PDK1PDK3PDK4SMN1; SMN2
SCHEMBL8067688 0.85 TSHR (0.42) PDK2PDK1PDK3PDK4SMN1; SMN2
SCHEMBL11886827 0.85 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1LMNAKDM4EKMT2A
SCHEMBL8062228 0.84 GSTO1 (0.48) SMN1; SMN2ALDH1A1LMNAKDM4EGSTO1
SCHEMBL8067685 0.82 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1LMNAKDM4EKMT2A
SCHEMBL8054565 0.82 POLB (0.47) SMN1; SMN2ALDH1A1LMNAKDM4EKMT2A
SCHEMBL8062230 0.81 TSHR (0.51) SMN1; SMN2ALDH1A1LMNAKDM4EGSTO1
SCHEMBL18434303 0.79 ALDH1A1 (0.42) PDK2SMN1; SMN2ALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150366977-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366977-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS TNNT2, TNNI3, NQO1 PDK2 1195/4885PDK1 1409/4885PDK3 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback